IBEX (IBEX) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
The 2024 annual general meeting will be held virtually on December 5, 2024, with shareholders voting on three key proposals and reviewing audited financial statements for the fiscal year ended June 30, 2024.
The company qualifies as a "controlled company" under Nasdaq rules, with TRGI holding approximately 32% of outstanding shares and the right to appoint five of eight board members.
Forward-looking statements highlight risks related to demand for services and macroeconomic conditions, as detailed in the annual report.
Voting matters and shareholder proposals
Proposal 1: Set the maximum number of directors at eight.
Proposal 2: Elect three director nominees to serve until the next annual meeting or their earlier departure.
Proposal 3: Approve Deloitte & Touche LLP as auditor and authorize the Audit Committee to set remuneration for fiscal year ending June 30, 2025.
Shareholders may submit additional proposals for the 2025 meeting by specified deadlines.
Board of directors and corporate governance
The board currently consists of eight directors, with recent changes including resignations and new appointments effective October and December 2024.
Four of eight directors are independent under Nasdaq standards.
Board committees include Audit, Compensation, and Nominating and Governance, each with defined responsibilities and charters.
Board diversity matrix and director biographies are disclosed.
Non-employee directors receive a $75,000 annual cash retainer; no regular equity grants.
Latest events from IBEX
- Strong growth, high client retention, and AI-driven expansion define the company's outlook.IBEX
Sidoti March Small-Cap Virtual Conference18 Mar 2026 - Record revenue and EPS growth, raised FY2026 guidance, and strong digital and AI momentum.IBEX
Q2 20265 Feb 2026 - Record financials, margin expansion, and AI-driven growth set up for FY 2025.IBEX
Q4 202420 Jan 2026 - Record Q1 revenue, margin gains, and raised outlook driven by vertical growth and AI innovation.IBEX
Q1 202515 Jan 2026 - Record Q2 revenue, margin expansion, and raised FY25 guidance highlight strong growth momentum.IBEX
Q2 202511 Dec 2025 - Director nominee withdrawal prompts Board to address a new vacancy before the 2025 meeting.IBEX
Proxy Filing5 Dec 2025 - Board commits to simple majority for Bye-Laws changes, enhancing shareholder rights.IBEX
Proxy Filing1 Dec 2025 - Key votes on board, compensation, and auditor highlight governance and incentive plan updates.IBEX
Proxy Filing1 Dec 2025 - Independent Nominating Committee formed to enhance board governance and nomination transparency.IBEX
Proxy Filing24 Nov 2025